home / lobbying / lobbying_filings_raw

lobbying_filings_raw: 3dc971bd-686a-4e90-8ca2-e72662e3dc4f

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json
3dc971bd-686a-4e90-8ca2-e72662e3dc4f Q3 1386 AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY 102613 AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY 2018 third_quarter 2018-10-18T16:08:53.833000-04:00 200000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/3dc971bd-686a-4e90-8ca2-e72662e3dc4f/", "filing_uuid": "3dc971bd-686a-4e90-8ca2-e72662e3dc4f", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2018, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/3dc971bd-686a-4e90-8ca2-e72662e3dc4f/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "200000.00", "expenses_method": "c", "expenses_method_display": "Method C - Reporting amounts under section 162(e) of the Internal Revenue Code", "posted_by_name": "James C. Denneny III, MD", "dt_posted": "2018-10-18T16:08:53.833000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1650 Diagonal Road", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "ALEXANDRIA", "registrant_state": "VA", "registrant_zip": "22314", "registrant": {"id": 1386, "url": "https://lda.senate.gov/api/v1/registrants/1386/", "house_registrant_id": 32181, "name": "AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY", "description": null, "address_1": "1650 Diagonal Road", "address_2": null, "address_3": null, "address_4": null, "city": "ALEXANDRIA", "state": "VA", "state_display": "Virginia", "zip": "22314", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "RAHUL K. SHAH, MD, MBA", "contact_telephone": "+1 703-535-3721", "dt_updated": "2026-02-05T17:04:45.115485-05:00"}, "client": {"id": 102613, "url": "https://lda.senate.gov/api/v1/clients/102613/", "client_id": 12, "name": "AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "VA", "state_display": "Virginia", "country": "US", "country_display": "United States of America", "ppb_state": "VA", "ppb_state_display": "Virginia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-06"}, "lobbying_activities": [{"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "H.R. 1, the \"Tax Cuts and Jobs Act of 2018,\" all provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Federal \"Truth in Advertising\" legislation; in general.\n\nH.R. 3928, the \"Truth in Healthcare Marketing Act,\" all provisions.\n\nIssues pertaining to scope of practice; in general.\n\nHealth care reform efforts; in general.\n\nRepeal of the Affordable Care Act, in general.\n\nLetter to the Food and Drug Administration regarding the forthcoming regulations relating to the over-the-counter sale of hearing aids.\n\nLetter to the Food and Drug Administration regarding National Shortages of Lidocaine with Epinephrine, Lidocaine, and Other Local Anesthetics.\n\nCoalition Letter to the Department of Health and Human Services Office of the Inspector General regarding information blocking by Electronic Health Record Vendors.\n\nLetter to Congress regarding H.R. 5247/S. 204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, all provisions.\n\nH.Res.740, Expressing Support for the Designation of March 3, 2018, as World Hearing Day.\n\nH.R. 6, the SUPPORT for Patients and Communities Act; Section 303.\n\nS. 2852, the Pandemic All Hazards Preparedness and Advancing Innovation Act of 2018; provisions related to malpractice/tort reform and H.R. 1876.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 2276/S. 2575, the \"Audiology Patient Choice Act,\" all provisions.\n\nMedicare physician payment reform and implementation of the Medicare and CHIP Reauthorization Act of 2015, in general. \n\nMedicare physician payment reform and implementation of the Medicare and CHIP Reauthorization Act of 2015 related to the cost domain of the Merit-based Incentive Payment System.\n\nH.R. 1156, the \"Patient Access to Higher Quality Health Care Act of 2017,\" all provisions.\n\nH.R. 849/S. 260, the \"Protecting Seniors' Access to Medicare Act of 2017,\" all provisions.\n\nComments outlining concern with the November 2017 Medicare Payment Advisory Commission (MedPAC) discussion titled, \"Rebalancing the physician fee schedule towards primary care services.\" \n\nIssues pertaining to scope of practice, in general.\n\nComments urging the Centers for Medicare and Medicaid Services (CMS) to reduce the 2018 Merit-based Incentive Payment System (MIPS) reporting period from a calendar year to a minimum of 90 consecutive days.\n\nComments on the Medicare Hospital IPPS FY 2019 Proposed Rule communicating concerns about the agencys plans to remove the Public Health and Clinical Data Exchange objective by 2022.\n\nComments urging leaders of the U.S. Senate Committee on Finance not to co-sponsor and oppose any efforts to advance the \"Audiology Patient Choice Act\" (S. 2575).\n\nComments to the Centers for Medicare and Medicaid Services (CMS) regarding Medicare's designation of CPT Code 31241 Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery.\n\nCoalition letter to leaders of the U.S. House Committees on Ways & Means and Energy & Commerce regarding the Medicare Appropriate Use Criteria (AUC) Program for Advanced Diagnostic Imaging.\n\nCoalition letter to leaders of the U.S. Senate Committee on Finance regarding the Medicare Appropriate Use Criteria (AUC) Program for Advanced Diagnostic Imaging.\n\nCoalition letter to U.S. House Committees on Ways & Means and Energy and Commerce and U.S. Senate Committee on Finance regarding payment cuts for clinical lab tests in the Medicare program. \n\nCoalition letter to the CMS Administrator urging HHS to allow eligible clinicians utilizing a certified electronic health record to participate in a clinician-led qualified clinical data registry to qualify them as fully achieving all points from the MIPS program.\n\nCoalition letter to the CMS Administrator regarding the Evaluation and Management coding and payment recommendations included in the CY19 Medicare Physician Fee Schedule Proposed Rule.\n\nCoalition letter to U.S. House of Representatives requesting support of a letter to HHS Secretary Alex Azar regarding data information blocking guidelines as related to Qualified Clinical Data Registries.\n\nComments on the CY19 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule communicating support for proposed changes to reduce site of service disparities, as well as removal of CPT 31241 (Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery) from the Inpatient Only List. \n\nComments on the CY19 Medicare Physician Fee Schedule Proposed Rule regarding the proposed changes to documentation requirements, coding and payment for Evaluation and Management (E/M) services, application of the MPPR to E/M services, and the pricing and composition of balloon sinus surgery kits.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "H.R. 1892, the \"Bipartisan Budget Act of 2018,\" provisions related to healthcare. \n\nOpposition to H.R. 564 and any appropriations policy riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA).\n\nCoalition letter to members of U.S. House Committee on Appropriations regarding funding for universal newborn hearing screening programs, as authorized by H.R.1539/S.652 the \"Early Hearing Detection and Intervention (EHDI) Act of 2017.\" \n\nCoalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. \n\nCoalition letter to U.S. House Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill.\n\nCoalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars.\n\nFY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders.\n\nCoalition letter to leaders of the U.S. House Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks.\n\nCoalition letter to leaders of the U.S. Senate Appropriations Committee requesting funding for the Agency for Healthcare Research and Quality (AHRQ) at a level equal to or higher than the House and Senate marks.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TOB", "general_issue_code_display": "Tobacco", "description": "Opposition to H.R. 564 and any appropriations riders that would exempt some cigars, including flavored cigars, from regulation under the Family Smoking Prevention and Tobacco Control Act (TCA).\n\nSupport for any legislation and/or regulation requiring all non-grandfathered private health insurance plans to cover preventative services given an \"A\" or \"B\" rating by the U.S. Preventative Services Taskforce (USPSTF), especially provisions relating to comprehensive benefits for tobacco cessation services.\n\nOpposition to H.R. 1136, the \"FDA Deeming Authority Clarification Act of 2017,\" all provisions.\n\nComments supporting the Food and Drug Administration's initiative to move toward a product standard to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels.\n\nCoalition letter to U.S. Senate Appropriators to approve the authorized level of user fees for the FDA oversight of tobacco products and oppose efforts to limit FDA's authority as part of the FY 2019 Agriculture, Rural Development, and Food and Drug Administration and Related Agencies Appropriations Bill. \n\nCoalition letter to leaders of the U.S. House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, urging allocation of funds for the Centers for Disease Control and Prevention's Office on Smoking and Health.\n\nCoalition letter to leaders of the U.S. Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies urging allocation of funds for the Centers for Disease Control and Prevention's Office on Smoking and Health.\n\nCoalition letter to U.S. House and Senate Conferees regarding H.R. 6147, urging the conferees to reject all tobacco riders that would weaken FDA oversight of tobacco products, including e-cigarettes and cigars.\n\nFY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 6147); provisions related to Tobacco Policy Riders.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TOR", "general_issue_code_display": "Torts", "description": "H.R. 1215, the \"Protecting Access to Care Act,\" all provisions.\n\nH.R. 1704, the \"Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act,\" all provisions.\n\nH.R. 1876, the \"Good Samaritan Health Professionals Act of 2017,\" all provisions.\n\nComments urging floor action in regards to the Good Samaritan Health Professionals Act of 2018 (H.R. 1876).\n\nCoalition letter to the Speaker of the House in support of the Good Samaritan Health Professionals Act of 2018 (H.R. 1876).\n\nCoalition letter to leaders of the U.S. House Committee on Energy & Commerce requesting inclusion of H.R. 1876 in the Pandemic and All Hazards Preparedness Re-authorization Act of 2018 (S. 2852).\n\nS. 2852, the Pandemic All Hazards Preparedness and Advancing Innovation Act of 2018; provisions related to malpractice/tort reform and H.R. 1876.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 43215, "prefix": "mrs", "prefix_display": "MRS.", "first_name": "JOY", "nickname": null, "middle_name": "L", "last_name": "TRIMMER", "suffix": "jd", "suffix_display": "JD"}, "covered_position": null, "new": false}, {"lobbyist": {"id": 64801, "prefix": null, "prefix_display": null, "first_name": "AMELIA", "nickname": null, "middle_name": null, "last_name": "SUERMANN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68228, "prefix": null, "prefix_display": null, "first_name": "MAURA", "nickname": null, "middle_name": null, "last_name": "FARRELL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 253, "name": "Medicare Payment Advisory Commission (MedPAC)"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []}

Links from other tables

  • 6 rows from filing_uuid in lobbying_activities
  • 3 rows from filing_uuid in lobbying_lobbyists
Powered by Datasette · Queries took 18.402ms